knowledge -WSS

knowledge

author：hotspot 2025-08-30 01:02:51 - browse：4

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion.

Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price. Intercept expects the deal to close by the end of the year.

The transaction comes three months after the Food and Drug Administration rejected Intercept’s treatment for NASH, an increasingly common fatty liver disease perceived as a potential gold mine by drug companies. Intercept’s medicine, called obeticholic acid, would have been the first approved treatment for NASH, but serious concerns about the risk of drug-related liver damage and uncertainty over whether its modest effects would improve patients’ lives made it unapprovable in the eyes of the FDA.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： STAT Report: Patient voices and perspectives

WSS

How doctors’ personal politics affect patients

New lawsuit accuses health insurer Cigna of denying claims in bulk

U.K. officials, researchers try to ease path for bespoke genetic treatments

What it's like to live with paralysis for one psychologist

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

6 surprising facts about sugar

leisure time

knowledge

leisure time

In age of alternative facts, a scholarly course on calling out crap

Diabetes management: Digital health tools fall short, study says

23andMe had bad news about my health. I wish a person had delivered it

Search called off for baby washed away in Pennsylvania flash flood

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Hepatitis C has a cure — but many Americans still lack access to it

Bring on the sabbaticals for nurses

What does generative AI mean for health care? We asked experts

Biogen says it will cut costs by $700 million, slash 1,000 jobs

entertainment

Diabetes management: Digital health tools fall short, study says

Surgeons perform first xenotransplant using CRISPR'd pig kidney

What Kate Middleton's cancer revelation might teach the world

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Why patients can’t get everything they want on drug pricing

Asbestos ban is immediate, but health effects will linger for decades

entertainment

hotspot

focus

leisure time